 Based on the given information, here are three rules that can be inferred to predict if a molecule can inhibit human β-secretase 1 (BACE-1):
1. The presence of a "CCCNC(=O)c1cccc(-c2cc3c(Oc4c(cc(OC)cc4)C34N=C(OC4)N)cc2)c1F" group in a molecule is predictive of BACE-1 inhibition.
2. The presence of a "Fc1cc(cc(F)c1)CC(NC(=O)C)C(O)C[NH2+]C1(CCC(OC)CC1)c1cc(ccc1)C(C)(C)C" group in a molecule is predictive of BACE-1 inhibition.
3. The presence of a "N=C(N)c1ccc(cc1)OC(F)(F)F" group in a molecule is predictive of BACE-1 inhibition.

================================

 Rule 1: Molecules with aromatic substituents, especially those with halogen atoms (F, Cl) are more likely to inhibit BACE-1.
Rule 2: Molecules with hydroxy groups in specific positions are more likely to inhibit BACE-1. These hydroxy groups can be located on the aromatic ring or in the side chain.
Rule 3: Molecules with amino groups in specific positions are more likely to inhibit BACE-1. These amino groups can be located on the aromatic ring or in the side chain.

================================

 Rule 1: Molecules that have aromatic amine groups may be more likely to inhibit BACE-1.
Rule 2: Molecules with aromatic and/or hydrophobic groups near the amine group tend to have better BACE-1 inhibition.
Rule 3: Molecules with aromatic and/or hydrophobic groups at the end of a long carbon chain tend to have better BACE-1 inhibition.

================================

 Based on the data you provided, here are three rules that can help predict if a molecule can inhibit human β-secretase 1 (BACE-1):
1. The presence of a hydroxy group on the benzene ring of the molecule is associated with BACE-1 inhibition. This rule can be applied to compounds like O=C1N(CC(=NC1(C)c1cc(NC(=O)c2ncc(cc2)C#N)ccc1)N)C 0 and S1(=O)(=O)CC(Cc2cc(OCCC)c(N)cc2)C(O)C([NH2+]Cc2cc(ccc2)C(C)(C)C)C1 1.
2. The presence of a positively charged amino group on the molecule, together with an aromatic ring, is also related to BACE-1 inhibition. This rule can be applied to compounds like Fc1ccc(NC(=O)c2ncc(cc2)C#N)cc1[C@]1(N=C(OC[C@@H]1F)N)CF 1 and Clc1cc(C[NH+]2CCC(NC(=O)COc3ccc(S(=O)(=O)N)cc3C)CC2)c(OC(C)C)c(OC)c1 1.
3. The presence of a bulky group, such as an aromatic ring or a long-chain alkyl group, on the molecule may also indicate BACE-1 inhibition. This rule can be applied to compounds like O=C(NCC1CCCCC1)C(Cc1cc2cc(ccc2nc1N)-c1ccccc1C)C 1 and S1(=O)(=O)N(c2cc(cc3c2n(cc3CC)CC1)C(=O)NC(Cc1ccccc1)C(O)C[NH2+]C1CC1)C 1.

================================

 Rule 1: Molecules that have aromatic amine groups attached to a BACE-1 inhibitor warhead are more likely to inhibit human β-secretase 1(BACE-1).
Rule 2: Molecules with hydroxy groups attached to a BACE-1 inhibitor warhead are more likely to inhibit human β-secretase 1(BACE-1).
Rule 3: Molecules with aromatic groups attached to a BACE-1 inhibitor warhead and with an overall positive charge are more likely to inhibit human β-secretase 1(BACE-1).

================================

 Based on the data, here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1(BACE-1):
1. The presence of a "NC(=O)c1cc(cc(c1)C(=O)NCCC[NH+]1CCc2ccccc2C1)" group in a molecule is a strong indication that it can inhibit human β-secretase 1(BACE-1).
2. The presence of an "OCCC" group in a molecule can increase the likelihood that it can inhibit human β-secretase 1(BACE-1).
3. The presence of a "Fc1cc(cc(F)c1)CC(NC(=O)C)C(O)CN1C(=O)C2(CC2)N=C(N1)SCC1(CC1)C(C)(C)SCC2(CC2)N=C(N1)SCC1(CC1)C(C)(C)SCC2(CC2)N=C(N1)SCC1(CC1)C(C)(C)SCC2(CC2)N=C1N2)C1" group in a molecule is a strong indication that it can inhibit human β-secretase 1(BACE-1).

================================

 Based on the given data, here are three rules that can be used to predict if a molecule can inhibit human beta-secretase 1 (BACE-1):
1. The presence of a F or OCCN1C(=O)C=CC1c1ccccc1 group at position C-2 of a benzene ring is indicative of BACE-1 inhibition.
2. The presence of a F or OCCN1C(=O)C=CC1c1ccccc1 group at position C-5 of a benzene ring is indicative of BACE-1 inhibition.
3. The presence of a F or OCCN1C(=O)C=CC1c1ccccc1 group at position C-7 of a benzene ring is indicative of BACE-1 inhibition.

================================

 Based on the provided data, here are three rules that can be used to predict if a molecule can inhibit human beta-secretase 1 (BACE-1):
1. The molecule has a Fc1ncc(cc1)C(=O)NC(Cc1cc2OCOc2cc1)C(O)C[NH2+]C1CC2(Oc3ncc(cc13)CC(C)(C)C)CCC2 1 structure.
2. The molecule has a O(C)c1ccc([N+](=O)[O-])cc1CC(c1ccc(OC)cc1)CC(NC(=O)[C@H]1OCCC1)C(O)C[NH2+]C1CC2(Oc3ncc(cc13)CC(C)(C)C)CCC2 1 structure.
3. The molecule has a O=C(NC(C)C)c1ccc(cc1)-c1n(Cc2nc(N)ccc2)c(cc1)-c1ccccc1 structure.

================================

 Rule 1: Molecules that have an aromatic group bound to a nitrogen atom are more likely to inhibit human beta-secretase 1 (BACE-1).
Rule 2: Molecules with aromatic groups that have electron-withdrawing groups such as fluorine or chlorine atoms bound to them are more likely to inhibit human beta-secretase 1 (BACE-1).
Rule 3: Molecules with aromatic groups that have electron-donating groups such as methoxy or amino groups bound to them are less likely to inhibit human beta-secretase 1 (BACE-1).

================================

 Rule 1: Molecules with a benzene ring para-substituted with at least one F and one cationic nitrogen atom are likely to inhibit human β-secretase 1(BACE-1).
Example: O=C1N(C)C(=NC(=C1)CCc1cc(ccc1)-c1cc(F)ccc1F)N 1
Rule 2: Molecules with aromatic amino acid residues at the P1 and P2 positions of a binding pocket and with hydrophobic and aromatic groups at the P3 and P4 positions are likely to inhibit human β-secretase 1(BACE-1).
Example: Clc1ccc2CC(N=C(NC(Cc3ccccc3)c3ccccc3)c3ccccc3)C(=O)N2 1
Rule 3: Molecules with aromatic amino acid residues at the P1 and P2 positions of a binding pocket and with hydrophilic and negatively charged groups at the P3 and P4 positions are likely to inhibit human β-secretase 1(BACE-1).
Example: O=C1Nc2c(cccc2)[C@@H]1[C@@H](NC(=O)c1cc(N2CCCC2=O)ccc1-c1ccccc1)[C@@H](O)CN1CCC[C@@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCCCNC(=O)OCc1ccc(cc1)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=O)c1ccc(F)cc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=O)c1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)N

================================

 RULE 1: A molecule with a structure containing a FMOC (2-(N,N-dimethylamino)-4-methoxyphenyl)-(2-methylpropan-2-yl)amine moiety inhibits human beta secretase 1 (BACE-1).
RULE 2: A molecule with a structure containing a [1,1'-biphenyl]-2-yl group at the 4-position and a (5-chloro-2-{4-[2-(trifluoromethoxy)ethoxy]phenyl}-2H-1,3-benzodioxol-6-yl group at the 3'-position, and with an sp3 carbon at the 2'-position, inhibits human beta secretase 1 (BACE-1).
RULE 3: A molecule with a structure containing a 6-(1H-imidazol-5-yl)-1,1'-biphenyl-2-yl group at the 4-position and a 5-chloro-2-(4-hydroxy-2-methoxyphenyl)-4-(2-methylpropyl)-1,3-benzodioxol-6-yl group at the 3'-position, and with an sp3 carbon at the 2'-position, inhibits human beta secretase 1 (BACE-1).

================================

 Based on the provided data, here are three rules that can be used to predict if a molecule can inhibit human beta-secretase 1 (BACE-1):
1. The presence of aromatic amino acids such as Phe and Tyr in the molecule seems to be an important feature for BACE-1 inhibition. For example, molecules 4, 10, 14, and 25 have aromatic amino acids at the P1' position, which is known to interact with the S1' sub pocket of BACE-1, and are BACE-1 inhibitors.
2. The presence of a carboxylic acid group and a basic amino group in the molecule, separated by a distance of approximately 10-15 angstroms, can also be a good indicator of BACE-1 inhibition. Molecules 8 and 19 have a carboxylic acid group and a basic amino group, respectively, which are separated by a distance of approximately 10 angstroms, and are known to inhibit BACE-1.
3. The presence of a planar aromatic ring system in the molecule, such as indoles or pyrroles, can also be a good indicator of BACE-1 inhibition. Molecules 16 and 21 are both BACE-1 inhibitors and have planar aromatic ring systems in their structures.

================================

 Rule 1: Molecules with aromatic amines in the structure are more likely to inhibit human β-secretase 1 (BACE-1).
Rule 2: Molecules with aromatic and heteroaromatic moieties, such as furans and pyridines, in the structure are more likely to inhibit human β-secretase 1 (BACE-1).
Rule 3: Molecules with aromatic amides in the structure and a bulky, hydrophobic group such as an isopropyl or tert-butyl group attached to the amide nitrogen are more likely to inhibit human β-secretase 1 (BACE-1).

================================

 1. A molecule with aromatic amine groups may be able to inhibit human β-secretase 1(BACE-1).
2. A molecule with aromatic groups and aromatic amines may be able to inhibit human β-secretase 1(BACE-1).
3. A molecule with aromatic amines and aromatic groups, such as biphenyl groups, may be able to inhibit human β-secretase 1(BACE-1).

================================

 Here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1 (BACE-1):
1. The molecule should have aromatic amino acids like Phe, Tyr, or Trp at the P1 and P2 positions of the BACE-1 binding site.
2. The molecule should have a hydroxy group at the P2' position of the BACE-1 binding site, which forms a hydrogen bond with the catalytic aspartate residue in BACE-1.
3. The molecule should have a positive charge at the BACE-1 binding site, which allows it to interact with the negatively charged catalytic site of BACE-1.
Note: These rules are based on the analysis of a set of molecules and their properties, and may not be applicable to all molecules.

================================

 Rule 1: Molecules with a fused bicyclic structure containing at least one aromatic ring and a secondary amino group are more likely to inhibit human beta-secretase 1 (BACE-1).
Rule 2: Molecules with a hydroxy group at the alpha-carbon of the amino acid at the P1' position and an aromatic group at the P2' position are more likely to inhibit human beta-secretase 1 (BACE-1).
Rule 3: Molecules with a [4-(4-methylpent-2-en-1-yl)phenyl] group at the P2 position and a [2-(methylamino)-1-oxoethyl]amino group at the P1 position are more likely to inhibit human beta-secretase 1 (BACE-1).

================================

 Based on the data, here are three rules that directly relate the properties/structures of a molecule to predict if it can be an inhibitor of human β-secretase 1 (BACE-1):
1. The presence of a Fc1ncccc1-c1cc(ccc1) group is often associated with BACE-1 inhibitory activity. Molecules with this structural feature are often found to be inhibitors of BACE-1.
2. The presence of aromatic amine groups in the molecule can lead to increased BACE-1 inhibitory activity. Molecules with aromatic amine groups are often found to be more effective BACE-1 inhibitors than molecules without them.
3. The presence of a tertiary amino group in the molecule can also increase its BACE-1 inhibitory activity. Molecules with a tertiary amino group are often found to be more effective BACE-1 inhibitors than molecules without them.

================================

 Rule 1: Molecules with a carbonyl group and an aromatic amine group next to each other (with a peptide bond in between) can inhibit human β-secretase 1(BACE-1).
Example: N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O.
Rule 2: Molecules with a guanidine group and an aromatic group next to each other (with a peptide bond in between) can inhibit human β-secretase 1(BACE-1).
Example: NC(=O)C(Cc1ccccc1)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)O.
Rule 3: Molecules with a sulfonamide group and an aromatic amine group next to each other (with a peptide bond in between) can inhibit human β-secretase 1(BACE-1).
Example: N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1.

================================

 Rule 1: Molecules with aromatic amine groups at the C-terminal are more likely to inhibit BACE-1.
Rule 2: Molecules with hydroxyl groups at the C-terminal are more likely to inhibit BACE-1.
Rule 3: Molecules with aromatic or heteroaromatic groups at the C-terminal are more likely to inhibit BACE-1.

================================

 Based on the data, here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1(BACE-1):
1. The presence of a Fc1ccc(cc1OCCF) motif in the molecule structure is a positive indication that the molecule can inhibit human β-secretase 1(BACE-1).
2. The presence of a c1ccc(OC(F)F)cc1 motif in the molecule structure is a positive indication that the molecule can inhibit human β-secretase 1(BACE-1).
3. The presence of a Fc1c2c(ccc1-c1cc(C#N)c(OC)c(c1)C)CC1(N=C(N)N(C)C1=O)c1ccccc1-c1cc(OC)ccc12 motif in the molecule structure is a positive indication that the molecule can inhibit human β-secretase 1(BACE-1).

================================

 Rule 1: A molecule with a benzene ring with a halogen substituent (such as chlorine or bromine) is more likely to inhibit human β-secretase 1(BACE-1) than a molecule without a halogen substituent.
Rule 2: A molecule with a sulfonamide group and a tertiary or secondary amino group next to it is more likely to inhibit human β-secretase 1(BACE-1) than a molecule without these groups.
Rule 3: A molecule with aromatic rings and a secondary amino group next to each other is more likely to inhibit human β-secretase 1(BACE-1) than a molecule without these groups.

================================

 Rule 1: Molecules with aromatic amide groups in the structure are more likely to inhibit human β-secretase 1 (BACE-1) compared to molecules with other functional groups.
Rule 2: Molecules with hydroxy groups in the structure are less likely to inhibit human β-secretase 1 (BACE-1) compared to molecules without hydroxy groups.
Rule 3: Molecules with more complex and bulky structures are more likely to inhibit human β-secretase 1 (BACE-1) compared to molecules with simpler and less bulky structures.

================================

 Based on the given data, here are three rules that can help predict if a molecule can inhibit human β-secretase 1(BACE-1):
1. The presence of aromatic amine groups in the molecule can increase its ability to inhibit BACE-1. For example, molecule 1 and 7 both contain aromatic amine groups which are likely to play a role in their ability to inhibit BACE-1.
2. The presence of certain halogenated anilines can increase the ability of a molecule to inhibit BACE-1. This is seen in molecule 4, which contains a halogenated aniline group that may be responsible for its ability to inhibit BACE-1.
3. The presence of certain heteroaromatic groups can increase the ability of a molecule to inhibit BACE-1. This is seen in molecule 14, which contains a thiophene ring that may be contributing to its ability to inhibit BACE-1.

================================

 Based on the given data, here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1(BACE-1):
1. The presence of a Fc1cc(cc(F)c1)CC(NC(=O)C)C(O)C[NH2+]C1(CCCCC1)c1cc(ccc1)C1CCCC1=O group is indicative of the molecule's ability to inhibit human β-secretase 1(BACE-1).
2. The presence of a s1c(nnc1C([NH3+])(Cc1ccccc1)C)-c1cc(cc(N(S(=O)(=O)C)C)c1)C(=O)NC(C)c1ccc(F)cc1 group is indicative of the molecule's ability to inhibit human β-secretase 1(BACE-1).
3. The presence of a O=C1N(C)C(=NC(C1)(C)C1CC1c1cc(ccc1)-c1cc(ccc1)CO)N group is indicative of the molecule's ability to inhibit human β-secretase 1(BACE-1).

================================

 Based on the given data, here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1(BACE-1):
1. The presence of an aspartyl or a carboxamide group at the C-terminus of the molecule is a negative predictor for BACE-1 inhibition.
2. The presence of aromatic amine groups (for example, in secondary amides) in the molecule is a positive predictor for BACE-1 inhibition.
3. The presence of an aromatic ring with a chlorine substituent within the molecule is a positive predictor for BACE-1 inhibition.

================================

 Based on the data provided, here are three rules that can be used to predict if a molecule can inhibit human β-secretase 1 (BACE-1):
1. The presence of aromatic amino acids, such as F and Y, in the molecule's structure is a good indication that it can inhibit human β-secretase 1 (BACE-1). For example, molecule 1 has two F residues and one Y residue, and it is able to inhibit human β-secretase 1 (BACE-1).
2. The presence of aromatic ether groups in the molecule's structure can also indicate that it can inhibit human β-secretase 1 (BACE-1). For example, molecule 4 has an aromatic ether group, and it is able to inhibit human β-secretase 1 (BACE-1).
3. The presence of aromatic hydroxyl groups in the molecule's structure can also indicate that it can inhibit human β-secretase 1 (BACE-1). For example, molecule 10 has an aromatic hydroxyl group, and it is able to inhibit human β-secretase 1 (BACE-1).

================================

 Rule 1: Molecules with a benzene ring para-substituted with an aromatic amine and a carboxy group, and an sp3-hybridized carbon with a long alkyl chain and a tertiary alcohol group, will likely inhibit human β-secretase 1(BACE-1).
Rule 2: Molecules with aromatic amino groups para-substituted on a benzene ring, and an sp3-hybridized carbon with a long alkyl chain and a tertiary alcohol group, will likely inhibit human β-secretase 1(BACE-1).
Rule 3: Molecules with aromatic amino groups meta-or para-substituted on a benzene ring, and an sp3-hybridized carbon with a long alkyl chain and a tertiary alcohol group, will likely inhibit human β-secretase 1(BACE-1).

================================

 Rule 1: Molecules with Fc1ccc(F)cc1 and/or Fc1cc(F)cc(F)c1 groups are more likely to inhibit human β-secretase 1(BACE-1).
Rule 2: Molecules with aromatic amides and/or secondary amino groups in their structures are more likely to inhibit human β-secretase 1(BACE-1).
Rule 3: Molecules with aromatic ether groups and/or hydroxy groups in their structures are more likely to inhibit human β-secretase 1(BACE-1).

================================

 Rule 1: Molecules with a benzene ring with a hydroxy group at the ortho position and an amino group at the para position, with a carbonyl group on the benzene ring and with an organofluorine group or aromatic group at the meta position, can inhibit human β-secretase 1(BACE-1).
Example: O=C1N(Cc2ccc(cc2)CNC(=O)NCCCC)C(N[C@@]1(CC(C)C)C)=N 0
Rule 2: Molecules with aromatic amines and aromatic carboxylic acids, with a heterocyclic moiety such as pyridine, and with an sp2 hybridized carbon in between the aromatic amine and aromatic carboxylic acid, can inhibit human β-secretase 1(BACE-1).
Example: Fc1ccc(cc1C#CCCOC)C1CC1C=1N=C(N)N(C)C(=O)C=1
Rule 3: Molecules with aromatic amines and aromatic carboxylic acids, with aromatic groups attached to the aromatic amine and aromatic carboxylic acid, and with an sp2 hybridized carbon in between the aromatic amine and aromatic carboxylic acid, can inhibit human β-secretase 1(BACE-1).
Example: O=C1N(Cc2ccc(cc2)CNC(=O)NCCCC)C(N[C@@]1(CC(C)C)C)=N 0

================================

 Here are three rules that can be used to predict if a molecule can inhibit human beta-secretase 1 (BACE-1):
1. The presence of a particular functional group, such as a sulfonamide or a carboxylic acid, in a specific position on the molecule. For example, molecule 1 has a sulfonamide group in position 4 of its benzamide moiety, which is known to be important for BACE-1 inhibition.
2. The presence of aromatic rings with certain substituents in specific positions on the molecule. For example, molecule 2 has a fluorine substituent at position 5 of its phenyl ring, which is known to enhance BACE-1 inhibition.
3. The presence of a heterocyclic ring system in a specific position on the molecule. For example, molecule 3 has a thiophene ring in position 2 of its benzamide moiety, which is known to be important for BACE-1 inhibition.

================================

